8.79
1.74%
+0.15
SIGA Technologies Inc stock is currently priced at $8.79, with a 24-hour trading volume of 454.30K.
It has seen a +1.74% increased in the last 24 hours and a +5.65% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $8.61 pivot point. If it approaches the $8.82 resistance level, significant changes may occur.
Previous Close:
$8.64
Open:
$8.68
24h Volume:
454.30K
Market Cap:
$624.90M
Revenue:
$139.92M
Net Income/Loss:
$68.07M
P/E Ratio:
23.13
EPS:
0.38
Net Cash Flow:
$94.78M
1W Performance:
+5.40%
1M Performance:
+5.65%
6M Performance:
+70.02%
1Y Performance:
+60.11%
SIGA Technologies Inc Stock (SIGA) Company Profile
Name
SIGA Technologies Inc
Sector
Phone
212-672-9100
Address
27 East 62nd Street, New York, NY
SIGA Technologies Inc Stock (SIGA) Latest News
Siga Technologies Inc. (SIGA) Stock Moves -0.23%: What You Should Know
Zacks Investment Research
Siga Technologies Inc. (SIGA) Increases Despite Market Slip: Here's What You Need to Know
Zacks Investment Research
Siga Technologies Inc. (SIGA) Advances While Market Declines: Some Information for Investors
Zacks Investment Research
Best Momentum Stocks to Buy for April 12th
Zacks Investment Research
New Strong Buy Stocks for April 12th
Zacks Investment Research
Best Value Stocks to Buy for April 12th
Zacks Investment Research
SIGA Technologies Inc Stock (SIGA) Financials Data
SIGA Technologies Inc (SIGA) Revenue 2024
SIGA reported a revenue (TTM) of $139.92 million for the quarter ending December 31, 2023, a +26.31% rise year-over-year.
SIGA Technologies Inc (SIGA) Net Income 2024
SIGA net income (TTM) was $68.07 million for the quarter ending December 31, 2023, a +100.76% increase year-over-year.
SIGA Technologies Inc (SIGA) Cash Flow 2024
SIGA recorded a free cash flow (TTM) of $94.78 million for the quarter ending December 31, 2023, a +127.77% increase year-over-year.
SIGA Technologies Inc (SIGA) Earnings per Share 2024
SIGA earnings per share (TTM) was $0.95 for the quarter ending December 31, 2023, a +111.11% growth year-over-year.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
Cap:
|
Volume (24h):